The Health System Costs of Potentially Inappropriate Prescribing: A Population-Based, Retrospective Cohort Study Using Linked Health Administrative Databases in Ontario, Canada [0.03%]
不合理处方的潜在成本：一项基于人群的回顾性队列研究，在加拿大多伦多健康行政数据库中进行的一项研究
Cody D Black,Kednapa Thavorn,Doug Coyle et al.
Cody D Black et al.
Objective: The aim of this study was to determine the health system costs from hospitalizations, emergency department (ED) visits, and medications due to potentially inappropriate prescribing (PIP) in Ontario, Canada, at ...
Long-Term Inpatient Hospital Utilisation and Costs (2007-2008 to 2015-2016) for Publicly Waitlisted Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia's Activity-Based Funding Model [0.03%]
基于澳大利亚活性资助模式的长期住院利用和成本（2007-2008至2015-2016）：按体重指数分类的公立等候名单上的代谢及减肥手术患者分析
Julie A Campbell,Martin Hensher,Daniel Davies et al.
Julie A Campbell et al.
Background: Within the Australian public hospital setting, no studies have previously reported total hospital utilisation and costs (pre/postoperatively) and costed patient-level pathways for primary bariatric surgery and...
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden [0.03%]
一项前瞻性登记队列研究：瑞典多发性硬化症患者诊断后的前五年医疗保健、病假和残障退休成本的轨迹分布
Korinna Karampampa,Hanna Gyllensten,Fei Yang et al.
Korinna Karampampa et al.
Objectives: The aim was to longitudinally explore the healthcare, sickness absence (SA), and disability pension (DP) cost trajectories among newly diagnosed people with multiple sclerosis (MS), and investigate whether tra...
Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis [0.03%]
计划级访问限制对类风湿性或银屑病关节炎患者生物制剂有效性的的影响
Natalie Boytsov,Xiang Zhang,Kristin A Evans et al.
Natalie Boytsov et al.
Background: Novel disease-modifying antirheumatic drugs (DMARDs) can slow disease progression among patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA); however, some health plans require prior authoriza...
Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia [0.03%]
与抗胆碱能药物相比，米拉贝隆在哥伦比亚成人过度活跃型膀胱病治疗中的成本效益分析
Hélène Parise,Robert Espinosa,Katherine Dea et al.
Hélène Parise et al.
Objectives: The aim of this study was to evaluate the cost effectiveness of mirabegron relative to two antimuscarinics, oxybutynin extended release (ER) and tolterodine ER, in patients with overactive bladder (OAB) from t...
A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers [0.03%]
静脉腿部溃疡治疗的基于模型的经济评价系统性回顾
Ashley Layer,Emma McManus,N J Levell
Ashley Layer
Objective: The aim of this review was to identify, and assess the quality of, published model-based economic evaluations relating to treatments for patients with venous leg ulcers to help inform future decision-analytic m...
Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas [0.03%]
免费结直肠癌筛查试验在人口主要居住地为美国得克萨斯州东北部的未参保或参保不足的农村人群中的投资回报率
Gabriela Orsak,Anastasia Miller,Carlton M Allen et al.
Gabriela Orsak et al.
Background: Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. ...
Correction to: Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations [0.03%]
对临床试验同期开展时间贸易off研究的案例及建议的更正通知
Jing Shen,Sarah Hill,David Mott et al.
Jing Shen et al.
The Open Access license, which previously read.
Published Erratum
PharmacoEconomics - open. 2019 Sep;3(3):427. DOI:10.1007/s41669-019-0145-0 2019
An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public Hospitals [0.03%]
基于希腊公立医院癌症诊断相关分组(DRG)实施情况的评价研究
Panos Panagiotopoulos,Nikos Maniadakis,George Papatheodoridis et al.
Panos Panagiotopoulos et al.
Objectives: The main aims of this study were to evaluate the Greek version of the diagnosis-related group reimbursement system (KEN-DRG) and to compare the KEN-DRG prices with the average actual cost of each group of stud...
Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights [0.03%]
原发性开角型青光眼的经济评价系统综述：决策分析建模见解
Jose Bartelt-Hofer,Lilia Ben-Debba,Steffen Flessa
Jose Bartelt-Hofer
Objective: Our objective was to review, compare and gain insight into economic evaluations in primary open-angle glaucoma (POAG) with a focus on existing decision analytic models. ...